Robert M. Kotin, “Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy”, (1994), Human Gene Therapy 5:793-801.* |
Allen, J. et al., “Identification and Elimination of Replication-Competent Adeno-Associated Virus (AAV) That Can Arise by Nonhomologous Recombination during AAV Vector Production,” J Virol 1997 Sep;71(9):6816-22. |
Flotte, T. et al., “An Improved System for Packaging Recombinant Adeno-Associated Virus Vectors Capable of in Vivo Transduction,” Gene Ther 1995 Jan;2(1);29-37. |
Grimm, D. et al., “Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use,” Hum Gene Ther 1999 Oct 10;10(15):2445-50. |
Li, J. et al., “Role for Highly Regulated rep Gene Expression in Adeno-Associated Virus Vector Production,” J Virol 1997 Jul;71(7):5236-43. |
Wang, X. et al., “Characterization of Wild-Type Adeno-Associated Virus Type 2-Like Particles Generated During Recombinant Viral Vector Production and Strategies for Their Elimination,” J. Virol 1998 Jul;72(7):5472-80. |